Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #18

    Der er udsigt til en indledende nervøs dansk aktiehandel med mindre fald. Der er dog ikke udsigt til nogen meget negativ start. Dels har aktierne allerede reageret lidt på Corona og dels er smitten trods alt koncentreret i Kina. https://blog.nordnet.dk/kinesisk-aktiepanik/?fbclid=IwAR2uFmmTg2dY_EngYOZADiYu-upTuHDoDQC5Bbv3G3IYJBJOxbcD8QdALHE

    1 Reply Last reply
    0
    • T Offline
      T Offline
      transalp
      wrote on sidst redigeret af
      #19

      Go morgen. 🙂

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #20

        CNBC
        ·

        US futures point to higher open despite coronavirus fears. https://www.cnbc.com/2020/02/03/us-futures-point-to-higher-open-despite-coronavirus-fears.html?__source=twitter|main

        1 Reply Last reply
        0
        • H Offline
          H Offline
          Hamming
          wrote on sidst redigeret af
          #21

          Link Preview Image
          Antibody-drug conjugates on the march

          One of AstraZeneca’s most decisive moves last year came when it signed a multi-billion dollar deal with Daiichi Sankyo, focused on just one breast cancer drug. We spoke with Daiichi's Gilles Gallant about the future plans for the drug, and the antibody-drug conjugate technology behind it

          favicon

          pharmaphorum (pharmaphorum.com)

          1 Reply Last reply
          0
          • H Offline
            H Offline
            Hamming
            wrote on sidst redigeret af
            #22

            Lidt interessant ift. Genmabs ADC´er

            1 Reply Last reply
            0
            • H Offline
              H Offline
              Hamming
              wrote on sidst redigeret af
              #23

              Daiichi mener også, at der er plads/brug for ADC´er

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #24

                Ligeledes Zymeworks som med ZW49 har en direkte konkurrent til DS8201 - blot med et bispecifikt ADC.

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gentogen
                  wrote on sidst redigeret af
                  #25

                  Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies. Journal of Geriatric Oncology
                  Volume 11, Issue 1, January 2020

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    gentogen
                    wrote on sidst redigeret af
                    #26

                    ofatumumab may represent an additional option to treat post-transplant FSGS relapse in patients who respond poorly to rituximab. Our experience suggests that its effectiveness could be related to prolonged depletion of potentially pathogenic switched memory B cells. Pediatric Nephrology volume 35, pages341–345(2020)

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      gentogen
                      wrote on sidst redigeret af
                      #27

                      Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness. Ofatumumab could be a safe and cost/effective rescue therapy for patients with MN sensitised against rituximab. BMJ CVase Reports

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        GeorgeBest
                        wrote on sidst redigeret af
                        #28

                        Er der et nyt marked for Ofa i CLL?

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          GeorgeBest
                          wrote on sidst redigeret af
                          #29

                          Jeg troede at Ofa var en død sild i cancer?

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bikube
                            wrote on sidst redigeret af
                            #30

                            Flot luk i dagens højeste 1579,50

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #31

                              tak gentogen

                              1 Reply Last reply
                              0
                              • DarvinD Offline
                                DarvinD Offline
                                Darvin
                                wrote on sidst redigeret af
                                #32

                                Ja - Noget kunne tyde på at vi også skal se efter OFA i Call. Linket fra imorges omhandlerogså OFA’s resultater.

                                1 Reply Last reply
                                0
                                • DarvinD Offline
                                  DarvinD Offline
                                  Darvin
                                  wrote on sidst redigeret af
                                  #33

                                  Der er en PDF at læse

                                  1 Reply Last reply
                                  0
                                  • DarvinD Offline
                                    DarvinD Offline
                                    Darvin
                                    wrote on sidst redigeret af
                                    #34

                                    Sat i forhold til Rituximab: High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      bibob
                                      wrote on sidst redigeret af
                                      #35

                                      God morgen. 🙂 BioNTech. https://m.firstwordpharma.com/biontech-announces-commencement-public-offering-american-depositary-shares

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #36

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #37

                                          Abwehrkampf gegen Leukämie - https://www.welt.de/print/die_welt/article205575129/Abwehrkampf-gegen-Leukaemie.html

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger